
Greenwich LifeSciences rose 136.2% from $8.15 to $19.25, ahead of the S&P 500's +4.7%. Its worst day was Aug 28 (−16.3%), and its low came Nov 24 at $7.85.
Nov 21, 2025 – Nov 20, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Greenwich LifeSciences closed at its lowest level of the year, 3.7% below where the year started.
−3.7% · S&P 500 +1.5%
Greenwich LifeSciences stock hits a new 52-week high!
Story events cover the past 12 months · Times ET
+20.2% · S&P 500 0.0%
Greenwich LifeSciences shares rose 21.7%, while the S&P 500 fell 0.3%.
+21.7% · S&P 500 −0.3%
Greenwich LifeSciences closed at its highest level of the year, 311.8% above where the year started.
+9.6% · S&P 500 +0.4%
EPS of $-0.58 missed the $-0.32 estimate on $0.00 revenue.
−14.8% · S&P 500 +0.1%
EPS of $-0.27 beat the $-0.33 estimate on $0.00 revenue.
+8.8% · S&P 500 +0.3%
EPS of $-0.40 missed the $-0.33 estimate on $0.00 revenue.
+35.9%, the year's best day · S&P 500 −1.0%
Where it ended: a close of $19.25 on Nov 20, 2026.
Nothing in the past 12 months.
All GLSI dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for GLSI and SPY from Benzinga historical bars. Not investment advice.